| Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung | |
| Goss, G.; Felip, E.; Cobo, M.; Lu, S.; Syrigos, K.; Lee, K. H.; Goker, E.; Georgoulias, V.; Li, W.; Guclu, S. | |
| 刊名 | JOURNAL OF THORACIC ONCOLOGY
 |
| 2017 | |
| 卷号 | 12期号:11 |
| 关键词 | NSCLC Squamous cell carcinoma afatinib |
| ISSN号 | 1556-0864 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3537720 |
| 专题 | 吉林大学白求恩第一医院 |
| 推荐引用方式 GB/T 7714 | Goss, G.,Felip, E.,Cobo, M.,et al. Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung[J]. JOURNAL OF THORACIC ONCOLOGY,2017,12(11). |
| APA | Goss, G..,Felip, E..,Cobo, M..,Lu, S..,Syrigos, K..,...&Soria, J..(2017).Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung.JOURNAL OF THORACIC ONCOLOGY,12(11). |
| MLA | Goss, G.,et al."Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung".JOURNAL OF THORACIC ONCOLOGY 12.11(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论